WuXi Nextcode

The new funds will help WuXi NextCode advance and commercialize genomic tests for the Chinese market, and strengthen its position in informatics.

At the ACMG annual conference in Phoenix last week, several labs and companies discussed their efforts in healthy genome sequencing.

At the American College of Medical Genetics and Genomics annual meeting in Phoenix, WuXi presented results from a pilot study involving 190 individuals.

WuXi NextCode will integrate Geneformics' compression technology into its workflows to provide rapid, easy access to genomic datasets.

The partners will use population genomics to discover and develop novel therapeutics and companion diagnostics for a range of chronic diseases.

The company will develop a data warehouse that integrates whole-genome sequence, medical, and wearables data from patients and controls.

The partners are combining their expertise to build a cloud-based infrastructure that will support the delivery of the China Precision Medicine Initiative.

The Simons Simplex Collection of genomic data from 2,600 simplex autism families is accessible through WuXi NextCode's cloud-based database.

It is also the first such lab in China to be licensed by the State of California, allowing it to process samples from the state.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.